Lifecore Biomedical Inc

LFCR - Insider Information

Get informed when a big investor buys or sells

Market Cap$243.36M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Lifecore Biomedical Inc	-3.4	-	37%	2.1	-3.1

$6.28

Target Price by Analysts

2.2% downsideLifecore Biomedical Target Price Details

$7.79

Current Fair Value

21.3% upside

Undervalued by 21.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap	$243.36 Million
Enterprise Value	$448.14 Million
Earnings per Share	$-0.92
Beta	0.99
Outstanding Shares	37,845,478

Return

Return on Equity	36.72%
Return on Assets	-11.81%
Return on Invested Capital	5.29%

Valuation & Multiples

P/E Ratio	-3.4
PEG	2.67
Price to Sales	2.14
Price to Book Ratio	-6.42
Enterprise Value to Revenue	3.62
Enterprise Value to EBIT	41.07
Enterprise Value to Net Income	-17
Total Debt to Enterprise	0.51
Debt to Equity	-3.1

Revenue Sources

No data

Last Earnings Call

Report Date

November 4, 2026

EPS

-$1.08

Est. -$0.30

Revenue

$25.32 M

Est. $25.57 M

Next Earnings Call

Expected Date

March 15, 2027

EPS Estimate

-$0.10

Consensus analyst estimate

Revenue Estimate

$38.67 M

Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio	0.0000▼ 33.55%
Total Calls	-▼ 100.00%
Total Puts	5,000▼ 75.85%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	5.04%▼ 63.00%
Total Invested	$12.47M▼ 90.68%
Investors Holding	38▼ 66.00%

About Lifecore Biomedical Inc

796 employees

CEO: Albert Bolles

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...